| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2019 | Aryeh Jason | Director | Buy | 750 | $87.01 | $65,257.50 | +1.1% | |
| Aug 5, 2019 | Aryeh Jason | Director | Buy | 746 | $90.01 | $67,145.97 | +1.1% | |
| Aug 2, 2019 | Patel Sunil | Director | Buy | 1,000 | $95.98 | $95,980.00 | +3.9% | |
| Aug 2, 2019 | Davis Todd C77 | Director | Buy | 1,000 | $93.59 | $93,594.40 | +2.1% | |
| Jul 31, 2019 | Sabba Stephen L | Director | Sell | 4,091 | $94.45 | $386,394.95 | -14.8% | |
| Jul 31, 2019 | Higgins John L66 | Chief Executive Officer | Buy | 1,850 | $95.45 | $176,582.50 | +1.3% | |
| Jul 31, 2019 | Aryeh Jason | Director | Buy | 4,004 | $99.22 | $397,286.75 | +2.1% | |
| Jun 11, 2019 | Aryeh Jason | Director | Buy | 250 | $107.01 | $26,752.50 | +0.4% | |
| May 31, 2019 | Higgins John L66 | Chief Executive Officer | Buy | 1,000 | $108.20 | $108,202.00 | +0.7% | |
| May 31, 2019 | Aryeh Jason | Director | Buy | 1,000 | $109.51 | $109,510.00 | +0.6% |